device · product 1 of 1
Access SARS-CoV-2 Antigen, REF C68668, UDI: (01)15099590742713, 3.30 mL/R1a, 4.70 mL/R1b, 4.20 mL/R1c, 3.10 mL, R1d, 3.10 mL, R1e
- Recall number
- Z-1670-2021
- Initiated
- April 14, 2021
- Classification
- Class II
- Status
- Terminated
- Recalling firm
- Beckman Coulter Inc.
- Quantity
- 1,034 units
App-derived interpretation
specimens collected in transport media may result is false negative results when stored in certain conditions.
Official device-enrichment evidence · Unknown
An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.
Inspect official wording and provenance
Reason for recall
specimens collected in transport media may result is false negative results when stored in certain conditions.
Code information
All Lots
Distribution pattern
Worldwide distribution - US Nationwide distribution in the states of Alabama, Arizona, Arkansas, California, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia, West Virginia and the country of New Zealand.